David P. Southwell, Director at PTC THERAPEUTICS, INC. (PTCT), sold 22,858 shares at $50.69 ($1.2M) on 2023-04-17, disclosed to the SEC on 2023-04-19.
Scheduled sale ($1.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.69 | 6,241 | $316K | 27.1% |
| 2 | $50.69 | 6,241 | $316K | 27.1% |
| 3 | $51.43 | 5,188 | $267K | 22.9% |
| 4 | $51.43 | 5,188 | $267K | 22.9% |
| Total | $51.03 avg | 22,858 | $1.2M | 100% |
| Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |
| TCRX | BUY | 2022-05-20 | $90K | — | Filing → |